Today: 21 May 2026
Interstellar comet 3I/ATLAS spills its secrets as scientists clock its water loss and radio silence
2 January 2026
2 mins read

Interstellar comet 3I/ATLAS spills its secrets as scientists clock its water loss and radio silence

NEW YORK, January 2, 2026, 12:50 ET

  • New analysis using SOHO data estimates how much water 3I/ATLAS released after its closest pass by the Sun
  • Breakthrough Listen researchers reported no credible narrowband radio “technosignatures” from the object
  • Amateur astronomers are still trying to photograph the faint comet during January

Astronomers have measured water streaming from interstellar comet 3I/ATLAS after it passed closest to the Sun, using ultraviolet observations that track hydrogen released as water breaks apart, a report published on Friday said.

The finding matters because 3I/ATLAS is only the third confirmed object known to have entered the solar system from interstellar space. Scientists treat such visitors as time-limited samples of material formed around another star, and this one is still being followed as it recedes.

NASA has said the comet is on a hyperbolic trajectory — a one-time flyby rather than a closed orbit around the Sun — and poses no threat to Earth. The agency said it will stay about 1.8 astronomical units away at its closest, where one astronomical unit is the average Earth–Sun distance.

A preprint submitted to The Astrophysical Journal Letters said SOHO’s SWAN instrument began observing the comet’s hydrogen coma on Nov. 6, 2025 — nine days after perihelion, its closest point to the Sun. The authors estimated a peak water production rate of 3.17×10^29 molecules per second at a heliocentric distance of 1.40 AU, falling to about 1–2×10^28 molecules per second by Dec. 8.

SOHO, a joint ESA/NASA mission, sits about 1.5 million kilometers from Earth, and SWAN was built to map ultraviolet light from hydrogen across the sky rather than image the Sun itself. Universe Today said the instrument can infer a comet’s water output by measuring the hydrogen glow created after sunlight splits water molecules.

The post-perihelion measurements are a key gap for 3I/ATLAS, because many early studies focused on the comet as it was heating up on the way in. Tracking the decline as it moved outward helps researchers compare its behavior with comets born in the solar system.

The comet’s high profile has also drawn attention from SETI efforts — searches for signals that might indicate extraterrestrial technology. A “technosignature” is any detectable sign of advanced technology, such as an artificial radio transmission.

In a Jan. 1 report, space journalist Leonard David wrote that the Breakthrough Listen program used the 100-meter Green Bank Telescope to look for narrowband radio signals — a tight slice of frequencies that can stand out against natural background noise. Lead author Ben Jacobson-Bell “reports ‘we find no credible detections of narrowband radio technosignatures originating from 3I/ATLAS.’” Leonarddavid

Gadgets 360 reported that the search scanned 1–12 gigahertz and that signals flagged in initial processing were later attributed to Earth-based interference, leaving no evidence of an artificial transmitter stronger than 0.1 watts at the object’s location.

For skywatchers, the comet remains a challenging target. BBC Sky at Night Magazine said 3I/ATLAS was expected to be around magnitude +15.6 on Jan. 1 — generally requiring imaging equipment rather than naked-eye viewing — and it tracks from the constellation Leo toward Cancer in January.

The object has become a flashpoint for broader debates about how the world should handle rare interstellar arrivals. In a Times of Israel blog post, writer Rafi Glick called 3I/ATLAS a “wake-up call” and argued for a more coordinated strategy for studying interstellar objects as detection rates rise. Timesofisrael

Stock Market Today

  • Coca-Cola and Beverage Sector Show Mixed Q1 Performance with Vita Coco Leading Gains
    May 20, 2026, 9:22 PM EDT. As Q1 earnings wrap up, beverages, alcohol, and tobacco stocks report mixed results. The sector beat revenue estimates by 4.9%, though next-quarter guidance fell short by 0.6%. Coca-Cola (NYSE:KO) posted strong growth with $12.47 billion in revenue, exceeding estimates by 2.5%, and shares rose 7.7%. Leading the pack was Vita Coco (NASDAQ:COCO), with a 37.3% revenue surge and a 54.1% stock gain post-earnings. In contrast, Boston Beer (NYSE:SAM) saw a 4.4% revenue decline and missed on operating income forecasts, marking the weakest performance among peers. Shifting consumer trends and social media-driven lower brand launch costs are reshaping competition in the sector.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Boeing (BA) stock jumps today as $2.7 billion Apache support deal kicks off 2026 trading
Previous Story

Boeing (BA) stock jumps today as $2.7 billion Apache support deal kicks off 2026 trading

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal
Next Story

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal

Go toTop